Our analysis reveals an inverse correlation between UCA1 and FAM171A2 expression, suggesting that UCA1-mediated oncogenic signaling may suppress FAM171A2-associated regulatory pathways, thereby enhancing drug resistance mechanisms in ovarian cancer cells. Here, UCA1 is linked to ovarian carcinoma.